ID: ALA1092482

Max Phase: Preclinical

Molecular Formula: C25H42ClN3O

Molecular Weight: 399.62

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCCCc1ccc(C(=O)NC2(C(=N)N)CC2)cc1.Cl

Standard InChI:  InChI=1S/C25H41N3O.ClH/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-21-15-17-22(18-16-21)23(29)28-25(19-20-25)24(26)27;/h15-18H,2-14,19-20H2,1H3,(H3,26,27)(H,28,29);1H

Standard InChI Key:  HMNUHPIJEQLUDW-UHFFFAOYSA-N

Associated Targets(Human)

Sphingosine kinase 1 1990 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Sphingosine kinase 2 214 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 399.62Molecular Weight (Monoisotopic): 399.3250AlogP: 6.13#Rotatable Bonds: 16
Polar Surface Area: 78.97Molecular Species: BASEHBA: 2HBD: 3
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 11.11CX LogP: 6.77CX LogD: 4.38
Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.18Np Likeness Score: -0.19

References

1. Mathews TP, Kennedy AJ, Kharel Y, Kennedy PC, Nicoara O, Sunkara M, Morris AJ, Wamhoff BR, Lynch KR, Macdonald TL..  (2010)  Discovery, biological evaluation, and structure-activity relationship of amidine based sphingosine kinase inhibitors.,  53  (7): [PMID:20205392] [10.1021/jm901860h]

Source